GI & Endoscopy

Michael Gurney, MD, is a gastroenterologist at Canton, Ohio-based Gastroenterology Specialists.

Alan Gunderson, MD, is a gastroenterologist at Iowa City-based University of Iowa Hospitals and Clinics.

Torax Medical's Linx completed its Caliber trial and found it was more effective than omeprazole in controlling regurgitation and improving quality of life for patients with gastroesophageal reflux disease.

Enki Endoscopy Report Writer incorporated GIQuIC certification into its quality reporting platform.

The FDA granted accelerated approval to Keytruda, an adult and pediatric treatment for unresectable or metastatic solid tumors identified as having a biomarker.

AmSurg, Evolution Health and other industry-leading organizations gathered at a GI Research Summit, March 2 at Envision Healthcare's Nashville, Tenn. headquarters, to discuss how to study and leverage GIQuIC data in pursuit of Healthcare Quadruple Aim.

Here are four GI companies in the headlines from the past week.

Benjamin Schaus, DO, is a gastroenterologist at Buffalo (N.Y.) Gastroenterology Associates.

The Minnesota Safety Council recognized Takeda Pharmaceuticals for excellence in workplace safety.

A study published in the Annals of Internal Medicine examined interval colorectal cancer risks in minorities.